Back
Grand Canyon Education Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
70
LOPE
Grand Canyon Education
Last Price:
170.02
Seasonality Move:
-0.23%
Buy
71
LBPH
Longboard Pharmaceuticals
Last Price:
59.76
Seasonality Move:
76.52%
Buy
70
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $170.56. The Score for LOPE is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $59.78. The Score for LBPH is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $170.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $59.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.82 | Buy |
| Relative Strength Index (14 RSI): | 83.68 | Buy |
| Chaikin Money Flow: | 25030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.7 - 151.86) | Buy |
| Bollinger Bands (100): | (134.88 - 150.1) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.63 | Buy |
| Relative Strength Index (14 RSI): | 80.51 | Buy |
| Chaikin Money Flow: | -417643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.61 - 64.55) | Buy |
| Bollinger Bands (100): | (27.56 - 49.76) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 152.14 | Buy |
| 20-day SMA: | 141.15 | Buy |
| 50-day SMA: | 140.71 | Buy |
| 200-day SMA: | 139.03 | Buy |
| 8-day EMA: | 156.5 | Buy |
| 20-day EMA: | 146.45 | Buy |
| 50-day EMA: | 142.4 | Buy |
| 200-day EMA: | 137.98 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.72 | Buy |
| 20-day SMA: | 59.54 | Buy |
| 50-day SMA: | 44.08 | Buy |
| 200-day SMA: | 29.37 | Buy |
| 8-day EMA: | 59.56 | Buy |
| 20-day EMA: | 56.23 | Buy |
| 50-day EMA: | 47.87 | Buy |
| 200-day EMA: | 31.78 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.74 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.46 per share.
Grand Canyon Education Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||